Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Appointed director
CC transcript

Synaptogenix, Inc. (SNPX) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/22/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
11/22/2022 8-K Quarterly results
11/18/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Form of Certificate of Designations",
"Form of Warrant",
"Form of Purchase Agreement",
"Form of Registration Rights Agreement",
"Engagement Letter, by and between Synaptogenix, Inc. and Katalyst Securities LLC",
"Press Release"
08/25/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/25/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/16/2022 8-K Quarterly results
08/05/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/28/2022 EFFECT Form EFFECT - Notice of Effectiveness:
04/15/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/29/2022 10-K Annual Report for the period ended December 31, 2021
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2022 SC 13G/A HAYWOOD GEORGE WEAVER reports a 7% stake in Synaptogenix, Inc.
01/31/2022 SC 13G/A ALPHA CAPITAL ANSTALT reports a 4.5% stake in SYNAPTOGENIX, INC.
11/12/2021 10-Q Quarterly Report for the period ended September 30, 2021
10/01/2021 8-K Quarterly results
08/13/2021 10-Q Quarterly Report for the period ended June 30, 2021
08/13/2021 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
07/16/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/07/2021 SC 13G ALPHA CAPITAL ANSTALT reports a 5.5% stake in SYNAPTOGENIX, INC.
07/07/2021 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/07/2021 EFFECT Form EFFECT - Notice of Effectiveness:
07/02/2021 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
06/29/2021 D Form D - Notice of Exempt Offering of Securities:
06/25/2021 SC 13G INTRACOASTAL CAPITAL, LLC reports a 10% stake in Synaptogenix, Inc.
06/24/2021 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
06/21/2021 8-K Other Events
06/16/2021 8-K Quarterly results
06/04/2021 8-A12B Form 8-A12B - Registration of securities [Section 12(b)]:
05/14/2021 10-Q Quarterly Report for the period ended March 31, 2021
04/30/2021 8-K Financial Statements and Exhibits
Docs: "The unaudited pro forma consolidated balance sheet of the Company as of December 31, 2020"
04/30/2021 SC 13G Hewlett Fund LP reports a 9% stake in SYNAPTOGENIX, INC.
04/30/2021 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/30/2021 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy